These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17543524)

  • 1. Thyroid receptor ligands. Part 8: Thyromimetics derived from N-acylated-alpha-amino acid derivatives displaying modulated pharmacological selectivity compared with KB-141.
    Garg N; Li YL; Garcia Collazo AM; Litten C; Ryono DE; Zhang M; Caringal Y; Brigance RP; Meng W; Washburn WN; Agback P; Mellström K; Rehnmark S; Rahimi-Ghadim M; Norin T; Grynfarb M; Sandberg J; Grover G; Malm J
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4131-4. PubMed ID: 17543524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1.
    Ye L; Li YL; Mellström K; Mellin C; Bladh LG; Koehler K; Garg N; Garcia Collazo AM; Litten C; Husman B; Persson K; Ljunggren J; Grover G; Sleph PG; George R; Malm J
    J Med Chem; 2003 Apr; 46(9):1580-8. PubMed ID: 12699376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid receptor ligands. 3. Design and synthesis of 3,5-dihalo-4-alkoxyphenylalkanoic acids as indirect antagonists of the thyroid hormone receptor.
    Hedfors A; Appelqvist T; Carlsson B; Bladh LG; Litten C; Agback P; Grynfarb M; Koehler KF; Malm J
    J Med Chem; 2005 May; 48(9):3114-7. PubMed ID: 15857115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid receptor ligands. Part 4: 4'-amido bioisosteric ligands selective for the thyroid hormone receptor beta.
    Li YL; Litten C; Koehler KF; Mellström K; Garg N; Garcia Collazo AM; Färnegård M; Grynfarb M; Husman B; Sandberg J; Malm J
    Bioorg Med Chem Lett; 2006 Feb; 16(4):884-6. PubMed ID: 16303304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of novel 3-hydroxy-cyclobut-3-ene-1,2-dione derivatives as thyroid hormone receptor beta (TR-beta) selective ligands.
    Raval S; Raval P; Bandyopadhyay D; Soni K; Yevale D; Jogiya D; Modi H; Joharapurkar A; Gandhi N; Jain MR; Patel PR
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3919-24. PubMed ID: 18585912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential therapeutic applications of thyroid hormone analogs.
    Brenta G; Danzi S; Klein I
    Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):632-40. PubMed ID: 17710084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective thyroid hormone receptor-beta activation: a strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability.
    Grover GJ; Mellström K; Ye L; Malm J; Li YL; Bladh LG; Sleph PG; Smith MA; George R; Vennström B; Mookhtiar K; Horvath R; Speelman J; Egan D; Baxter JD
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):10067-72. PubMed ID: 12888625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid receptor ligands. 6. A high affinity "direct antagonist" selective for the thyroid hormone receptor.
    Koehler K; Gordon S; Brandt P; Carlsson B; Bäcksbro-Saeidi A; Apelqvist T; Agback P; Grover GJ; Nelson W; Grynfarb M; Färnegårdh M; Rehnmark S; Malm J
    J Med Chem; 2006 Nov; 49(23):6635-7. PubMed ID: 17154490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant-selective thyromimetics for the chemical rescue of thyroid hormone receptor mutants associated with resistance to thyroid hormone.
    Shi Y; Ye H; Link KH; Putnam MC; Hubner I; Dowdell S; Koh JT
    Biochemistry; 2005 Mar; 44(12):4612-26. PubMed ID: 15779888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABAA receptor pharmacology of fluorinated derivatives of the novel sedative-hypnotic pyrazolopyrimidine indiplon.
    Wegner F; Deuther-Conrad W; Scheunemann M; Brust P; Fischer S; Hiller A; Diekers M; Strecker K; Wohlfarth K; Allgaier C; Steinbach J; Hoepping A
    Eur J Pharmacol; 2008 Feb; 580(1-2):1-11. PubMed ID: 18035350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel indane derivatives as liver-selective thyroid hormone receptor β (TRβ) agonists for the treatment of dyslipidemia.
    Shiohara H; Nakamura T; Kikuchi N; Ozawa T; Nagano R; Matsuzawa A; Ohnota H; Miyamoto T; Ichikawa K; Hashizume K
    Bioorg Med Chem; 2012 Jun; 20(11):3622-34. PubMed ID: 22542282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor.
    Volpini R; Dal Ben D; Lambertucci C; Taffi S; Vittori S; Klotz KN; Cristalli G
    J Med Chem; 2007 Mar; 50(6):1222-30. PubMed ID: 17309246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new class of high affinity thyromimetics containing a phenyl-naphthylene core.
    Hangeland JJ; Friends TJ; Doweyko AM; Mellström K; Sandberg J; Grynfarb M; Ryono DE
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4579-84. PubMed ID: 16099653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioisosteric phentolamine analogs as selective human alpha(2)- versus alpha(1)-adrenoceptor ligands.
    Bavadekar SA; Hong SS; Lee SI; Miller DD; Feller DR
    Eur J Pharmacol; 2008 Aug; 590(1-3):53-60. PubMed ID: 18589415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid receptor ligands. Part 2: Thyromimetics with improved selectivity for the thyroid hormone receptor beta.
    Hangeland JJ; Doweyko AM; Dejneka T; Friends TJ; Devasthale P; Mellström K; Sandberg J; Grynfarb M; Sack JS; Einspahr H; Färnegårdh M; Husman B; Ljunggren J; Koehler K; Sheppard C; Malm J; Ryono DE
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3549-53. PubMed ID: 15177471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
    Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel thyroid hormone analogues, enzyme inhibitors and mimetics, and their action.
    Mondal S; Mugesh G
    Mol Cell Endocrinol; 2017 Dec; 458():91-104. PubMed ID: 28408161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,3-Dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines as potent A2B adenosine receptor antagonists: design, synthesis, structure-affinity and structure-selectivity relationships.
    Stefanachi A; Nicolotti O; Leonetti F; Cellamare S; Campagna F; Loza MI; Brea JM; Mazza F; Gavuzzo E; Carotti A
    Bioorg Med Chem; 2008 Nov; 16(22):9780-9. PubMed ID: 18938084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of 3-phenylnaphthalenic derivatives as new selective MT(2) melatoninergic ligands.
    Poissonnier-Durieux S; Ettaoussi M; Pérès B; Boutin JA; Audinot V; Bennejean C; Delagrange P; Caignard DH; Renard P; Berthelot P; Lesieur D; Yous S
    Bioorg Med Chem; 2008 Sep; 16(18):8339-48. PubMed ID: 18778943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Derivatives of 4-amino-6-hydroxy-2-mercaptopyrimidine as novel, potent, and selective A3 adenosine receptor antagonists.
    Cosimelli B; Greco G; Ehlardo M; Novellino E; Da Settimo F; Taliani S; La Motta C; Bellandi M; Tuccinardi T; Martinelli A; Ciampi O; Trincavelli ML; Martini C
    J Med Chem; 2008 Mar; 51(6):1764-70. PubMed ID: 18269230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.